4.6 Article

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study

期刊

出版社

WILEY
DOI: 10.1161/JAHA.121.023188

关键词

cancer; cardiovascular; death; infection

资金

  1. British Heart Foundation [FS/18/44/33792, FS/12/80/29821]
  2. British Heart Foundation [FS/18/44/33792, FS/12/80/29821] Funding Source: researchfish

向作者/读者索取更多资源

The study aimed to define the rates of cardiovascular and noncardiovascular death in people with specified cardiovascular diseases or accruing cardiovascular multimorbidity; findings showed that as cardiovascular multimorbidity increased, there was a greater proportion of cardiovascular and infection-related deaths; compared to those without cardiovascular diseases, individuals with three or more cardiovascular diseases experienced significantly higher incidence rate ratios for cardiovascular death.
Background Therapeutic advances have reduced cardiovascular death rates in people with cardiovascular diseases (CVD). We aimed to define the rates of cardiovascular and noncardiovascular death in people with specified CVDs or accruing cardiovascular multimorbidity. Methods and Results We studied 493 280 UK residents enrolled in the UK Biobank cohort study. The proportion of deaths attributed to cardiovascular, cancer, infection, or other causes were calculated in groups defined by 9 distinct self-reported CVDs at baseline, or by the number of these CVDs at baseline. Poisson regression analyses were then used to define adjusted incidence rate ratios for these causes of death, accounting for sociodemographic factors and comorbidity. Of 27 729 deaths, 20.4% were primarily attributed to CVD, 53.6% to cancer, 5.0% to infection, and 21.0% to other causes. As cardiovascular multimorbidity increased, the proportion of cardiovascular and infection-related deaths was greater, contrasting with cancer and other deaths. Compared with people without CVD, those with 3 or more CVDs experienced adjusted incidence rate ratios of 7.0 (6.2-7.8) for cardiovascular death, 4.4 (3.4-5.6) for infection death, 1.5 (1.4-1.7) for cancer death, and 2.0 (1.7-2.4) for other causes of death. There was substantial heterogeneity in causes of death, both in terms of crude proportions and adjusted incidence rate ratios, among the 9 studied baseline CVDs. Conclusions Noncardiovascular death is common in people with CVD, although its contribution varies widely between people with different CVDs. Holistic and personalized care are likely to be important tools for continuing to improve outcomes in people with CVD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据